Linked Life Data

2574066

Source:http://linkedlifedata.com/resource/pubmed/id/2574066

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1990-1-25
pubmed:abstractText
1. We have previously found that the putative 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) decreases hippocampal 5-hydroxytryptamine (5-HT) release in the anaesthetized rat, as measured by brain microdialysis. The present study attempted to characterize the receptor involved in this response using a range of monoamine receptor antagonists. 2. The classical 5-HT receptor antagonists, metergoline (5 mg kg-1 s.c.), methysergide (10 mg kg-1 s.c.) and methiothepin (10 mg kg-1 s.c.) each reduced dialysate levels of 5-HT which complicated their use as antagonists in these experiments. Nevertheless, pretreatment with metergoline but not methiothepin and methysergide partially reduced the 5-HT response to a maximally effective dose of 8-OH-DPAT (0.25 mg kg-1 s.c.). 3. The mixed 5-HT 1/beta-adrenoceptor antagonist pindolol (8 mg kg-1 s.c.) was without effect on spontaneous 5-HT output but attenuated the effect of both maximally (0.25 mg kg-1 s.c.) and submaximally (0.05 mg kg-1 s.c.) effective dose of 8-OH-DPAT. In comparison, propranolol (10 mg kg-1 s.c.) did not affect 5-HT output when injected alone and did not alter the response to 8-OH-DPAT (0.25 mg kg-1 s.c.). 4. The 5-HT2 receptor antagonist ritanserin (0.2 mg kg-1 s.c.) and the 5-HT3 receptor antagonist BRL 43694 (0.5 mg kg-1 s.c.) neither altered 5-HT output alone nor significantly changed the response to 8-OH-DPAT (0.25 mg kg-1 s.c.). 5. The 8-OH-DPAT (0.25 mg kg-' s.c.) response was not affected by pretreatment with either the dopamine D2-receptor antagonist sulpiride (10mgkg-1 s.c.) or the alpha/alpha 2-adrenoceptor antagonist phentolamine (10mg kg-1 s.c.). 6. We conclude from these data that the decrease of hippocampal 5-HT output induced by 8-OHDPAT does not involve 5-HT2, 5-HT3, adrenoceptors or dopamine D2-receptors and that activation of a 5-HT1 class of receptor seems probable. Full classification of the 8-OH-DPAT response awaits development of a suitably selective 5-HT1 receptor antagonist with low intrinsic activity at the somatodendritic 5-HT autoreceptor.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-2429847, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-2463453, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-2466516, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-2469021, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-2470860, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-2522986, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-2580582, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-2862270, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-2869415, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-2876903, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-2878817, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-2886356, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-2897920, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-2905533, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-2906291, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-2931289, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-2936965, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-2946964, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-2951611, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-3207999, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-326580, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-3290473, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-3505364, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-4155733, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-4823095, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-488172, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-530316, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-6132640, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-6223827, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-6238235, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-6241568, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-6261070, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-6468503, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-6602057, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-662027, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-7059349, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574066-7155196
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0007-1188
pubmed:author
pubmed:issnType
Print
pubmed:volume
98
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
989-97
pubmed:dateRevised
2010-3-29
pubmed:meshHeading
pubmed:year
1989
pubmed:articleTitle
Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis.
pubmed:affiliation
University Department of Clinical Pharmacology, Radcliffe Infirmary, Oxford.
More...